• Home
  • About Us
    • Board of Directors
    • Board Committees
  • Products
    • Anti Biotics & Anti Infectives
    • Beta-lactams- Penicillins
    • Antifungals
    • Miscellaneous
    • Vitamins & Supplements
    • Cardiovasculars
    • Antipyretic, Analgesic, NSAIDs
    • Antacid, Anti-Ulcer Drugs
    • Antidepressants, Antipsychotics
    • Antimalarials
    • Dry Syrups
    • Ointments & Creams
    • Anti-Diabetics
    • Syrups
  • Investors Relation
    • General Meetings
    • Shareholding Pattern
    • Stock Exchange Intimation
    • Investor Complaints
    • Investor Relation Announcements
    • Attendence Sheet & Proxy Form
    • Annual Report
    • Financials Results
    • Unpaid / Unclaimed Dividend
    • Policies
    • Memorandum of Association (MOA) and Articles of Association (AOA)
    • Integrated Filing - Governance
  • Contact Us

NOTICES & OUTCOMES


pdf-30 Reconciliation of Share Capital Audit March 2022

pdf-30 Certificate under Regulation 7(3) March 2022

pdf-30 Certificate under Regulation 40(9) March 2022

pdf-30 Closure of Trading Window 31.03.2022

pdf-30 Outcome of BM 12.11.2021

pdf-30 Intimation of BM 12.11.2021

pdf-30 Reconciliation of Share Capital Audit December 2021

pdf-30 Certificate under Regulation 7(3) March 2021

pdf-30 Reconciliation of Share Capital Audit September 2021

pdf-30 Outcome of BM 07.10.2021

pdf-30 Intimation of BM 07.10.2021

pdf-30 Closure of Trading Window 30.09.2021

pdf-30 Reconciliation of Share Capital Audit June 2021

pdf-30 Outcome of BM 27.05.21

pdf-30Intimation of BM 27.05.21

pdf-30 Reconciliation of Share Capital Audit March 2021

pdf-30 Certificate under Regulation 40(9) March 2021

pdf-30 Closure of Trading Window 31.03.2021

pdf-30 Reconciliation of Share Capital Audit December 2020

pdf-30 Outcome of BM 12.11.20

pdf-30 Intimation of BM 12.11.20

pdf-30 Certificate under Regulation 7(3) September 2020

pdf-30 Certificate under Regulation 40(9) September 2020

pdf-30 Reconciliation of Share Capital Audit September 2020

pdf-30Closure of Trading Window 30.09.2020

pdf-30 Reconciliation of Share Capital Audit June 2020


Our Company, Medico Remedies Limited, is a pharmaceutical formulation manufacturing company with manufacturing and marketing capabilities in formulation with focus on anti-infective, Beta-Lactums.

Contact info

  • Medico Remedies Limited
    Harshit Mehta(Director) 1105/1106, Hubtown Solaris, N.S.Phadke Marg, opp.teligali, Andheri East ,
    Mumbai-400069.
  • +91-22- 68943803
  • secretarialmrl@gmail.com

Link

  • About Us
  • Investor
  • Products
  • Contact Us

Connect With Us

©Copyright 2017 Medico Remedies Ltd : Design by :- Find Solution